Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis

Authors :: Hai Ya Wu
Miao Yu
Xiao Feng Lv
Guo Yue Yuan
Bin Zhang
Source :: Diabetes Therapy
Publication Year :: 2020
Publisher :: Springer Science and Business Media LLC, 2020.
Abstract: Introduction To evaluate the efficacy and safety of dulaglutide 0.75 and 1.5 mg in patients with type 2 diabetes mellitus (T2DM) by baseline glycated hemoglobin (HbA1c)

Tools